Advanced Medical Isotope (OTCMKTS:RDGL) Issues Quarterly Earnings Results

Advanced Medical Isotope (OTCMKTS:RDGL) announced its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $0.02 million during the quarter.

Advanced Medical Isotope Price Performance

RDGL traded up $0.00 during trading hours on Wednesday, reaching $0.09. 368,268 shares of the company’s stock traded hands, compared to its average volume of 516,585. The firm has a 50-day moving average price of $0.08 and a 200 day moving average price of $0.08. Advanced Medical Isotope has a 52-week low of $0.04 and a 52-week high of $0.17.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.